Gerald L Denardo

Professor Emeritus

  • 8365 Citations
  • 51 h-Index
1962 …2017
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1962 2017

Filter
Article
1998
38 Citations (Scopus)

A revolution in the treatment of non-Hodgkin's lymphoma

DeNardo, G. L., O'Donnell, R. T., Oldham, R. K. & DeNardo, S. J., 1998, In : Cancer Biotherapy and Radiopharmaceuticals. 13, 4, p. 213-223 11 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Biological Therapy
Proxy
Therapeutics
Radioisotopes
25 Citations (Scopus)

Combined modality radioimmunotherapy with taxol and 90Y-Lym-1 for Raji lymphoma xenografts

O'Donnell, R. T., DeNardo, S. J., Miers, L. A., Kukis, D. L., Mirick, G. R., Kroger, L. A. & Denardo, G. L., 1998, In : Cancer Biotherapy and Radiopharmaceuticals. 13, 5, p. 351-361 11 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Paclitaxel
Heterografts
Lymphoma
Nude Mice
26 Citations (Scopus)

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts

Denardo, G. L., Kroger, L. A., Meares, C. F., Richman, C. M., Salako, Q., Shen, S., Lamborn, K. R., Peterson, J. J., Miers, L. A., Zhong, G. R. & DeNardo, S. J., Oct 1998, In : Clinical Cancer Research. 4, 10, p. 2483-2490 8 p.

Research output: Contribution to journalArticle

Immunoconjugates
Heterografts
Breast Neoplasms
Peptides
Radioimmunotherapy
21 Citations (Scopus)

L6 monoclonal antibody binds prostate cancer

O'Donnell, R. T., DeNardo, S. J., Shi, X. B., Mirick, G. R., Denardo, G. L., Kroger, L. A. & Meyers, F. J., Oct 1 1998, In : Prostate. 37, 2, p. 91-97 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Monoclonal Antibodies
Nude Mice
Radioimmunotherapy
Heterografts
99 Citations (Scopus)

Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-LYM-1 antibody

Denardo, G. L., DeNardo, S. J., Lamborn, K. R., Goldstein, D. S., Levy, N. B., Lewis, J. P., O'Grady, L. F., Raventos, A., Kroger, L. A., Macey, D. J., McGahan, J. P., Mills, S. L. & Shen, S., 1998, In : Cancer Biotherapy and Radiopharmaceuticals. 13, 4, p. 239-254 16 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
B-Lymphocytes
Antibodies
Neoplasms
B-Cell Chronic Lymphocytic Leukemia
188 Citations (Scopus)

Maximum-tolerated dose, toxicity, and efficacy of 131I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Denardo, G. L., DeNardo, S. J., Goldstein, D. S., Kroger, L. A., Lamborn, K. R., Levy, N. B., McGahan, J. P., Salako, Q., Shen, S. & Lewis, J. P., Oct 1998, In : Journal of Clinical Oncology. 16, 10, p. 3246-3256 11 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Maximum Tolerated Dose
Non-Hodgkin's Lymphoma
Antibodies
Radiometry
65 Citations (Scopus)

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: A pilot study

Denardo, G. L., Denardo, S. J., Kukis, D. L., O'Donnell, R. T., Shen, S., Goldstein, D. S., Kroger, L. A., Salako, Q., Denardo, D. A., Mirick, G. R., Mausner, L. F., Srivastava, S. C. & Meares, C. F., Jul 1998, In : Anticancer Research. 18, 4 B, p. 2779-2788 10 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Maximum Tolerated Dose
Non-Hodgkin's Lymphoma
Radiation
Radiometry
25 Citations (Scopus)

New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor

Feng, X., Pak, R. H., Kroger, L. A., Moran, J. K., DeNardo, D. G., Meares, C. F., Denardo, G. L. & DeNardo, S. J., 1998, In : Hybridoma. 17, 2, p. 125-132 8 p.

Research output: Contribution to journalArticle

Radiopharmaceuticals
Monoclonal Antibodies
Neoplasms
Hybridomas
Yttrium
72 Citations (Scopus)

Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates

Kukis, D. L., DeNardo, S. J., DeNardo, G. L., O'Donnell, R. T. & Meares, C. F., Dec 1998, In : Journal of Nuclear Medicine. 39, 12, p. 2105-2110 6 p.

Research output: Contribution to journalArticle

Immunoconjugates
Yttrium
Radioimmunotherapy
Buffers
Reaction Time
17 Citations (Scopus)

Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody

DeNardo, S. J., Kroger, L. A., MacKenzie, M. R., Mirick, G. R., Shen, S. & Denardo, G. L., Feb 1998, In : Cancer Biotherapy and Radiopharmaceuticals. 13, 1, p. 1-12 12 p.

Research output: Contribution to journalArticle

Anti-Idiotypic Antibodies
Survival
Antibodies
Delayed Emergence from Anesthesia
Radioimmunotherapy
13 Citations (Scopus)

Quantification of iodine-131 in tumors using a threshold based on image contrast

Denardo, G. L., Shen, S., DeNardo, S. J., Liao, S. Q., Lamborn, K. R., DeNardo, D. A. & Yuan, A., 1998, In : European Journal Of Nuclear Medicine. 25, 5, p. 497-502 6 p.

Research output: Contribution to journalArticle

Iodine
Neoplasms
Radioactivity
Biopsy
29 Citations (Scopus)

Synergistic therapy of breast cancer with Y90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol

DeNardo, S. J., Richman, C. M., Kukis, D. L., Shen, S., Lamborn, K. R., Miers, L. A., Kroger, L. A., Perez, E. A. & Denardo, G. L., 1998, In : Anticancer Research. 18, 6 A, p. 4011-4018 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Clinical Protocols
Paclitaxel
Breast Neoplasms
Therapeutics
42 Citations (Scopus)

Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: Efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts

DeNardo, S. J., Kukis, D. L., Miers, L. A., Winthrop, M. D., Kroger, L. A., Salako, Q., Shen, S., Lamborn, K. R., Gumerlock, P. H., Meares, C. F. & DeNardo, G. L., May 1998, In : Journal of Nuclear Medicine. 39, 5, p. 842-849 8 p.

Research output: Contribution to journalArticle

Immunoconjugates
Heterografts
Breast Neoplasms
Maximum Tolerated Dose
Lethal Dose 50
1997
5 Citations (Scopus)

Decreased C-MYC and BCL2 expression correlates with methylprednisolone- mediated inhibition of Raji lymphoma growth

Morris, G., Denardo, S. J., Denardo, G. L., Leshchinsky, T., Wu, B., Mack, P., Winthrop, M. D. & Gumerlock, P. H., Apr 1997, In : Biochemical and Molecular Medicine. 60, 2, p. 108-115 8 p.

Research output: Contribution to journalArticle

Methylprednisolone
Lymphoma
Growth
Tumors
Withholding Treatment
51 Citations (Scopus)

Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji)

Denardo, G. L., Kukis, D. L., Shen, S., Mausner, L. F., Meares, C. F., Srivastava, S. C., Miers, L. A. & DeNardo, S. J., 1997, In : Clinical Cancer Research. 3, 1, p. 71-79 9 p.

Research output: Contribution to journalArticle

Immunoconjugates
Burkitt Lymphoma
Neoplasms
Lymphoma
Monoclonal Antibodies
11 Citations (Scopus)

Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2

Denardo, G. L., Kukis, D. L., DeNardo, S. J., Shen, S., Mausner, L. F., O'Donnell, R. T., Lamborn, K. R., Meyers, F. J., Srivastava, S. C. & Miers, L. A., Dec 15 1997, In : Cancer. 80, 12 SUPPL., p. 2576-2582 7 p.

Research output: Contribution to journalArticle

Burkitt Lymphoma
Interleukin-2
Therapeutics
Neoplasms
Radiation
28 Citations (Scopus)

Imaging for improved prediction of myelotoxicity after radioimmunotherapy

DeNardo, D. A., Denardo, G. L., O'Donnell, R. T., Lim, S. M., Shen, S., Yuan, A. & DeNardo, S. J., Dec 15 1997, In : Cancer. 80, 12 SUPPL., p. 2558-2566 9 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Bone Marrow
Radiation
Radioactivity
Biopsy
16 Citations (Scopus)

Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients B-lymphocytic malignancies

Shen, S., Denardo, G. L., O'Donnell, R. T., Yuan, A., DeNardo, D. A. & DeNardo, S. J., Dec 15 1997, In : Cancer. 80, 12 SUPPL., p. 2553-2557 5 p.

Research output: Contribution to journalArticle

Splenomegaly
Spleen
Neoplasms
Radiation
Therapeutics
25 Citations (Scopus)

Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma

DeNardo, S. J., Kroger, L. A., Lamborn, K. R., Miers, L. A., O'Donnell, R. T., Kukis, D. L., Richman, C. M. & Denardo, G. L., Dec 15 1997, In : Cancer. 80, 12 SUPPL., p. 2583-2590 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Paclitaxel
Breast Neoplasms
Peptides
Antibodies
59 Citations (Scopus)

Increased survival associated with radiolabeled Lym-1 therapy for non- Hodgkin's lymphoma and chronic lymphocytic leukemia

Denardo, G. L., Lamborn, K. R., Goldstein, D. S., Kroger, L. A. & DeNardo, S. J., Dec 15 1997, In : Cancer. 80, 12 SUPPL., p. 2706-2711 6 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Survival
Therapeutics
Radioimmunotherapy
9 Citations (Scopus)

Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma

Richman, C. M., Schuermann, T. C., Wun, T., Malik, R., O'Donnell, R. T., Denardo, G. L. & DeNardo, S. J., Dec 15 1997, In : Cancer. 80, 12 SUPPL., p. 2728-2732 5 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Radioimmunotherapy
Breast Neoplasms
Drug Therapy
Granulocyte-Macrophage Progenitor Cells
8 Citations (Scopus)

Practical determination of organ S values for individual patients for therapy

Shen, S., Denardo, G. L., Macey, D. J., O'Donnell, R. T., Yuan, A., DeNardo, D. A. & DeNardo, S. J., Jul 1997, In : Nuclear Medicine and Biology. 24, 5, p. 447-449 3 p.

Research output: Contribution to journalArticle

Radioisotopes
Reference Values
Radiation
Therapeutics
43 Citations (Scopus)

Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources

Lim, S. M., DeNardo, G. L., DeNardo, D. A., Shen, S., Yuan, A., O'Donnell, R. T. & DeNardo, S. J., Sep 1997, In : Journal of Nuclear Medicine. 38, 9, p. 1374-1378 5 p.

Research output: Contribution to journalArticle

Bone Marrow
Radiation
Hematocrit
Granulocytes
Linear Models
11 Citations (Scopus)

Prediction of myelotoxicity using semi-quantitative marrow image scores

Lim, S., DeNardo, G. L., DeNardo, D. A., O'Donnell, R. T., Yuan, A. & DeNardo, S. J., Nov 1997, In : Journal of Nuclear Medicine. 38, 11, p. 1749-1753 5 p.

Research output: Contribution to journalArticle

Bone Marrow
Radioimmunotherapy
Injections
Blood Cell Count
Body Surface Area
61 Citations (Scopus)

Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody

Denardo, S. J., O'Grady, L. F., Richman, C. M., Goldstein, D. S., O'Donnell, R. T., Denardo, D. A., Kroger, L. A., Lamborn, K. R., Hellström, K. E., Hellström, I. & Denardo, G. L., 1997, In : Anticancer Research. 17, 3 B, p. 1745-1751 7 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Breast Neoplasms
Antibodies
Neoplasms
Maximum Tolerated Dose
92 Citations (Scopus)

Radioimmunotherapy for breast cancer using indium- 111/Yttrium-90 BrE- 3: Results of a phase I clinical trial

DeNardo, S. J., Kramer, E. L., O'Donnell, R. T., Richman, C. M., Salako, Q. A., Shen, S., Noz, M., Glenn, S. D., Ceriani, R. L. & Denardo, G. L., 1997, In : Journal of Nuclear Medicine. 38, 8, p. 1180-1185 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Yttrium
Clinical Trials, Phase I
Indium
Pentetic Acid
20 Citations (Scopus)

Reproducibility of operator processing for radiation dosimetry

Shen, S., Denardo, G. L., DeNardo, S. J., Yuan, A., DeNardo, D. A. & Lamborn, K. R., Jan 1997, In : Nuclear Medicine and Biology. 24, 1, p. 77-83 7 p.

Research output: Contribution to journalArticle

Radiometry
Radioimmunotherapy
Half-Life
Radiation
Neoplasms
102 Citations (Scopus)

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

Denardo, S. J., Kukis, D. L., Kroger, L. A., O'Donnell, R. T., Lamborn, K. R., Miers, L. A., Denardo, D. G., Meares, C. F. & Denardo, G. L., Apr 15 1997, In : Proceedings of the National Academy of Sciences of the United States of America. 94, 8, p. 4000-4004 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Yttrium
Paclitaxel
Heterografts
Breast Neoplasms
28 Citations (Scopus)

Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies

Lamborn, K. R., Denardo, G. L., DeNardo, S. J., Goldstein, D. S., Shen, S., Larkin, E. C. & Kroger, L. A., Aug 1997, In : Clinical Cancer Research. 3, 8, p. 1253-1260 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Karnofsky Performance Status
Aptitude
Survival
Pharmacokinetics

Tribute to Ralph A. Reisfeld, Ph.D.

Denardo, G. L., Dec 15 1997, In : Cancer. 80, 12 Suppl, p. 2345-2346 2 p.

Research output: Contribution to journalArticle

20th Century History
Immunotherapy
Neoplasms
78 Citations (Scopus)

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: Pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer

Denardo, S. J., Richman, C. M., Goldstein, D. S., Shen, S., Sajlako, Q., Kukis, D. L., Meares, C. F., Yuan, A., Welborn, J. L. & Denardo, G. L., 1997, In : Anticancer Research. 17, 3 B, p. 1735-1744 10 p.

Research output: Contribution to journalArticle

Yttrium
Pharmacokinetics
Immunoconjugates
Breast Neoplasms
Peptides
1996
8 Citations (Scopus)

Accurate measurement of copper-67 in the presence of copper-64 contaminant using a dose calibrator

Denardo, G. L., Kukis, D. L., Shen, S. & DeNardo, S. J., Feb 1996, In : Journal of Nuclear Medicine. 37, 2, p. 302-306 5 p.

Research output: Contribution to journalArticle

Copper
Gamma Rays
Isotopes
Spectrum Analysis
Radiopharmaceuticals
59 Citations (Scopus)

Antibody responses to macrocycles in lymphoma

DeNardo, G. L., Mirick, G. R., Kroger, L. A., O'Donnell, R. T., Meares, C. F. & DeNardo, S. J., Mar 1996, In : Journal of Nuclear Medicine. 37, 3, p. 451-456 6 p.

Research output: Contribution to journalArticle

Antibody Formation
Lymphoma
Chelating Agents
Antibodies
Immunoconjugates
5 Citations (Scopus)

Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy

Wilder, R. B., Denardo, G. L., Sheri, S., Fowler, J. F., Wessels, B. W. & DeNardo, S. J., 1996, In : European Journal Of Nuclear Medicine. 23, 8, p. 953-957 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Linear Models
Bone Marrow
Platelet Count
Granulocytes
41 Citations (Scopus)

A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy

Erwin, W. D., Groch, M. W., Macey, D. J., Denardo, G. L., DeNardo, S. J. & Shen, S., May 1996, In : Nuclear Medicine and Biology. 23, 4, p. 525-532 8 p.

Research output: Contribution to journalArticle

Radioimmunodetection
Radioimmunotherapy
Radioisotopes
Clinical Medicine
Nuclear Medicine
26 Citations (Scopus)

Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy

Shen, S., Denardo, G. L., DeNardo, S. J., Salako, Q., Morris, G., Banks, D., Yuan, A. & DeNardo, D. A., Jan 1996, In : Journal of Nuclear Medicine. 37, 1, p. 146-150 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Copper
Radiation
Bone Marrow
Therapeutics
57 Citations (Scopus)

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10

Rose, L. M., Gunasekera, A. H., DeNardo, S. J., Denardo, G. L. & Meares, C. F., 1996, In : Cancer Immunology Immunotherapy. 43, 1, p. 26-30 5 p.

Research output: Contribution to journalArticle

Epitopes
Lymphoma
Light
Antigens
Antibodies
4 Citations (Scopus)
Radioimmunodetection
Kidney Tubules
Radioisotopes
Kidney
Amino Acids
36 Citations (Scopus)

Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies

DeNardo, D. A., DeNardo, G. L., Yuan, A., Shen, S., DeNardo, S. J., Macey, D. J., Lamborn, K. R., Mahe, M., Groch, M. W. & Erwin, W. D., Dec 1996, In : Journal of Nuclear Medicine. 37, 12, p. 1970-1975 6 p.

Research output: Contribution to journalArticle

Iodine
Radiotherapy
Antibodies
Bone Marrow
Therapeutics
1995
27 Citations (Scopus)

Analysis of antiglobulin (HAMA) response in a group of patients with B-lympkocytic malignancies treated with 131I-Lym-1

Denardo, G. L., Kroger, L. A., Mirick, G. R., Lamborn, K. R. & De Nardo, S. J., 1995, In : International Journal of Biological Markers. 10, 2, p. 67-74 8 p.

Research output: Contribution to journalArticle

Antibody Formation
Anti-Idiotypic Antibodies
Antibodies
Neoplasms
Human Development
94 Citations (Scopus)

Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates

Kukis, D. L., Denardo, G. L., DeNardo, S. J., Mirick, G. R., Miers, L. A., Greiner, D. P. & Meares, C. F., 1995, In : Cancer Research. 55, 4, p. 878-884 7 p.

Research output: Contribution to journalArticle

Immunoconjugates
Chelating Agents
Antibodies
Antigens
Competitive Binding
35 Citations (Scopus)

Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy

Macey, D. J., DeNardo, S. J., Denardo, G. L., DeNardo, D. A. & Shen, S., 1995, In : Clinical Nuclear Medicine. 20, 2, p. 117-125 9 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Bone Marrow
Radiation
B-Cell Chronic Lymphocytic Leukemia
37 Citations (Scopus)
Carcinoma, Ductal, Breast
Tumors
Monoclonal Antibodies
Tissue
Staining and Labeling
21 Citations (Scopus)

Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody

Breitz, H. B., Durham, J. S., Fisher, D. R., Weiden, P. L., Denardo, G. L., Goodgold, H. M. & Nelp, W. B., 1995, In : Journal of Nuclear Medicine. 36, 5, p. 754-761 8 p.

Research output: Contribution to journalArticle

Rhenium
Ascitic Fluid
Pharmacokinetics
Monoclonal Antibodies
Radioactivity
57 Citations (Scopus)

Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90- DOTA-peptide in tumor-bearing mice

DeNardo, S. J., Zhong, G. R., Salako, Q., Li, M., Denardo, G. L. & Meares, C. F., 1995, In : Journal of Nuclear Medicine. 36, 5, p. 829-836 8 p.

Research output: Contribution to journalArticle

Yttrium
Indium
Pharmacokinetics
Peptides
Neoplasms
18 Citations (Scopus)

Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies

Denardo, G. L., Lamborn, K. R., DeNardo, S. J., Goldstein, D. S., Dolber-Smith, E. G., Kroger, L. A., Larkin, E. C. & Shen, S., 1995, In : Cancer Research. 55, 23 SUPPL.

Research output: Contribution to journalArticle

Radioimmunotherapy
Neoplasms
Karnofsky Performance Status
Interleukin-2 Receptors
L-Lactate Dehydrogenase
60 Citations (Scopus)
Radioimmunotherapy
Blood Cells
Stem Cells
Breast Neoplasms
Antibodies
34 Citations (Scopus)

Radioimmunotherapy of lymphoma: A UC Davis experience

Lewis, J. P., Denardo, G. L. & Denardo, S. J., 1995, In : Hybridoma. 14, 2, p. 115-120 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Lymphoma
Neoplasms
B-Lymphocytes
Therapeutics
18 Citations (Scopus)

Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression

DeNardo, S. J., Gumerlock, P. H., Winthrop, M. D., Mack, P., Chi, S. G., Lamborn, K. R., Shen, S., Miers, L. A., deVere White, R. W. & Denardo, G. L., 1995, In : Cancer Research. 55, 23 SUPPL.

Research output: Contribution to journalArticle

Yttrium
Nude Mice
Apoptosis
Breast Neoplasms
Messenger RNA
1994
61 Citations (Scopus)

A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates

Kukis, D. L., Diril, H., Greiner, D. P., DeNardo, S. J., Denardo, G. L., Salako, Q. A. & Meares, C. F., 1994, In : Cancer. 73, SUPPL., p. 779-786 8 p.

Research output: Contribution to journalArticle

Immunoconjugates
Copper
Antibodies
Radioimmunotherapy
Chelating Agents